يعرض 1 - 10 نتائج من 53 نتيجة بحث عن '"2ND-LINE TREATMENT"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Hendriks , L E , Kerr , K M , Menis , J , Mok , T S , Nestle , U , Passaro , A , Planchard , D , Peters , S , Smit , E F , Solomon , B J , Veronesi , G , Reck , M , ESMO Guidelines Committee & Guidelines Committee , ESMO 2023 , ' Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 34 , no. 4 , pp. 358-376 . https://doi.org/10.1016/j.annonc.2022.12.013Test

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية
  3. 3
  4. 4
  5. 5
    دورية أكاديمية

    المصدر: Dingemans , A M C , Fruh , M , Ardizzoni , A , Besse , B , Faivre-Finn , C , Hendriks , L E , Lantuejoul , S , Peters , S , Reguart , N , Rudin , C M , De Ruysscher , D , Van Schil , P E , Vansteenkiste , J , Reck , M & ESMO Guidelines Committee 2021 , ' Small-cell lung cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 32 , no. 7 , pp. 839-853 . https://doi.org/10.1016/j.annonc.2021.03.207Test

  6. 6
    دورية أكاديمية

    المساهمون: HUS Comprehensive Cancer Center, Department of Oncology

    وصف الملف: application/pdf

    العلاقة: The study was funded by Exelixis, Inc. Patients treated at Memorial Sloan Kettering Cancer Center were supported in part by Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748). Medical writing and editorial support was provided by Suvajit Sen, PhD (Exelixis, Inc.), and Fishawack Communications Inc. (Conshohocken, PA, USA), whichwas funded by Exelixis.; Tannir , N M , Powles , T , Escudier , B , Donskov , F , Gruenwald , V , Sternberg , C N , Schmidinger , M , Schoeffski , P , Szczylik , C , Peltola , K , Nosov , D , Melichar , B , Clary , D , Scheffold , C , Motzer , R J & Choueiri , T K 2020 , ' Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma ' , Kidney cancer , vol. 4 , no. 1 , pp. 29-39 . https://doi.org/10.3233/KCA-190080Test; 68d06f7f-4b82-4e0f-8499-893165000e0a; http://hdl.handle.net/10138/333879Test; 000664215700004

  7. 7
    دورية أكاديمية
  8. 8
  9. 9
    دورية أكاديمية

    المصدر: Belkouz , A , de Vos-Geelen , J , Mathot , R A A , Eskens , F A L M , van Gulik , T M , van Oijen , M G H , Punt , C J A , Wilmink , J W & Klumpen , H-J 2020 , ' Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer : an open-label, single arm, phase 2 trial ' , British Journal of Cancer , vol. 122 , no. 5 , pp. 634-639 . https://doi.org/10.1038/s41416-019-0698-9Test

  10. 10
    دورية أكاديمية

    المساهمون: Clinicum, Hematologian yksikkö, Department of Oncology, Department of Medicine, HUS Comprehensive Cancer Center, HUS Internal Medicine and Rehabilitation

    وصف الملف: application/pdf

    العلاقة: RN received financial support from Mallinckrodt Pharmaceuticals for collection and analysis of the patient data. The remaining authors have disclosed no conflicts of interest.; Niittyvuopio , R , Juvonen , E , Heiskanen , J , Lindstrom , V , Nihtinen , A , Sahlstedt , L & Volin , L 2018 , ' Extracorporeal photopheresis in the treatment of acute graft-versus-host disease : a single-center experience ' , Transfusion , vol. 58 , no. 8 , pp. 1973-1979 . https://doi.org/10.1111/trf.14649Test; 85046015273; d898305c-0da8-47b4-b334-240d508e8185; http://hdl.handle.net/10138/305621Test; 000444080700039